Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE: 000623)
China
· Delayed Price · Currency is CNY 17.27
-0.64 (-3.57%)
Dec 31, 2024, 3:04 PM CST
Jilin Aodong Pharmaceutical Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 2,959 | 3,404 | 2,850 | 2,263 | 2,237 | 3,081 | Upgrade
|
| Other Revenue | 45.58 | 45.58 | 17.95 | 41.05 | 15.11 | 6.99 | Upgrade
|
| Revenue | 3,005 | 3,449 | 2,868 | 2,304 | 2,252 | 3,088 | Upgrade
|
| Revenue Growth (YoY) | -9.20% | 20.25% | 24.50% | 2.31% | -27.09% | -7.09% | Upgrade
|
| Cost of Revenue | 1,764 | 1,768 | 1,417 | 1,111 | 929.01 | 970.88 | Upgrade
|
| Gross Profit | 1,241 | 1,681 | 1,451 | 1,193 | 1,323 | 2,117 | Upgrade
|
| Selling, General & Admin | 1,177 | 1,354 | 1,181 | 1,093 | 1,279 | 1,749 | Upgrade
|
| Research & Development | 121.18 | 124.98 | 85.68 | 49.42 | 67.21 | 142.9 | Upgrade
|
| Other Operating Expenses | 44.1 | 46.43 | 42.77 | 39.3 | 43.02 | 55.57 | Upgrade
|
| Operating Expenses | 1,338 | 1,546 | 1,321 | 1,187 | 1,388 | 1,944 | Upgrade
|
| Operating Income | -96.95 | 134.53 | 129.91 | 5.87 | -65.74 | 173.64 | Upgrade
|
| Interest Expense | -113.35 | -144.35 | -142.99 | -130.49 | -126.82 | -113.08 | Upgrade
|
| Interest & Investment Income | 1,544 | 1,382 | 1,697 | 2,070 | 1,916 | 1,338 | Upgrade
|
| Other Non Operating Income (Expenses) | 16.68 | -10.77 | 589.79 | -7.62 | -5.28 | -5.33 | Upgrade
|
| EBT Excluding Unusual Items | 1,350 | 1,361 | 2,274 | 1,937 | 1,718 | 1,394 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -24.28 | -48.41 | Upgrade
|
| Gain (Loss) on Sale of Investments | -137.03 | -111.06 | -632.66 | -259.53 | -75.98 | 26.44 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.68 | 36.16 | 3.16 | -0.94 | -0.64 | -0.19 | Upgrade
|
| Asset Writedown | -3.25 | -3.25 | -1.25 | -2.84 | -1.25 | -9.22 | Upgrade
|
| Other Unusual Items | 217.25 | 217.25 | 77.92 | 92.6 | 100.79 | 117.57 | Upgrade
|
| Pretax Income | 1,426 | 1,500 | 1,721 | 1,767 | 1,717 | 1,480 | Upgrade
|
| Income Tax Expense | 33.5 | 55.83 | -80.16 | -4.19 | 25.14 | 86.35 | Upgrade
|
| Earnings From Continuing Operations | 1,393 | 1,444 | 1,801 | 1,771 | 1,691 | 1,393 | Upgrade
|
| Minority Interest in Earnings | 36.86 | 15.54 | -20.2 | 9.64 | 17.46 | 10.24 | Upgrade
|
| Net Income | 1,430 | 1,460 | 1,781 | 1,781 | 1,709 | 1,404 | Upgrade
|
| Net Income to Common | 1,430 | 1,460 | 1,781 | 1,781 | 1,709 | 1,404 | Upgrade
|
| Net Income Growth | -34.25% | -18.02% | 0.02% | 4.19% | 21.75% | 50.09% | Upgrade
|
| Shares Outstanding (Basic) | 1,159 | 1,125 | 1,135 | 1,139 | 1,158 | 1,163 | Upgrade
|
| Shares Outstanding (Diluted) | 1,272 | 1,295 | 1,301 | 1,259 | 1,276 | 1,280 | Upgrade
|
| Shares Change (YoY) | -3.73% | -0.46% | 3.36% | -1.39% | -0.28% | 10.06% | Upgrade
|
| EPS (Basic) | 1.23 | 1.30 | 1.57 | 1.56 | 1.48 | 1.21 | Upgrade
|
| EPS (Diluted) | 1.23 | 1.23 | 1.47 | 1.51 | 1.43 | 1.18 | Upgrade
|
| EPS Growth | -29.66% | -16.35% | -2.93% | 5.70% | 20.92% | 47.01% | Upgrade
|
| Free Cash Flow | -74.24 | -351.46 | 152.89 | 11.54 | 163.02 | 157.06 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.27 | 0.12 | 0.01 | 0.13 | 0.12 | Upgrade
|
| Dividend Per Share | 0.800 | 0.600 | 0.300 | 0.300 | 0.200 | 0.200 | Upgrade
|
| Dividend Growth | 166.67% | 100.00% | 0% | 50.00% | 0% | 0% | Upgrade
|
| Gross Margin | 41.31% | 48.74% | 50.59% | 51.76% | 58.74% | 68.56% | Upgrade
|
| Operating Margin | -3.23% | 3.90% | 4.53% | 0.25% | -2.92% | 5.62% | Upgrade
|
| Profit Margin | 47.58% | 42.33% | 62.09% | 77.29% | 75.89% | 45.45% | Upgrade
|
| Free Cash Flow Margin | -2.47% | -10.19% | 5.33% | 0.50% | 7.24% | 5.09% | Upgrade
|
| EBITDA | 112.89 | 338.68 | 326.49 | 200.39 | 129.73 | 367.67 | Upgrade
|
| EBITDA Margin | 3.76% | 9.82% | 11.38% | 8.70% | 5.76% | 11.90% | Upgrade
|
| D&A For EBITDA | 209.83 | 204.15 | 196.58 | 194.53 | 195.46 | 194.02 | Upgrade
|
| EBIT | -96.95 | 134.53 | 129.91 | 5.87 | -65.74 | 173.64 | Upgrade
|
| EBIT Margin | -3.23% | 3.90% | 4.53% | 0.25% | -2.92% | 5.62% | Upgrade
|
| Effective Tax Rate | 2.35% | 3.72% | - | - | 1.46% | 5.84% | Upgrade
|
| Revenue as Reported | 3,005 | 3,449 | 2,868 | 2,304 | 2,252 | 3,088 | Upgrade
|
| Advertising Expenses | - | 277.99 | 202.59 | 160.73 | 212.53 | 399.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.